Pharmaceutical Sector Outlook 2026 Key Themes and Investment Considerations Prediction Markets Under Fire 16 States Take Legal Action One Enacts Ban Consumer Prices Rise 38 Annually in April Reaching Highest Level Since May 2023 Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Shifting Demand Trends Traders Bet on IonQ Micron and Anduril as Next Potential US Government Stake Targets Traders Skeptical of Irans Strait of Hormuz Reopening Timeline Prediction Market Data Shows Amneal Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency NTGR Q1 2026 Earnings Stellar EPS Surprise of 268 Drives Stock Higher MAGN Q1 2026 Earnings Wide EPS Miss Signals Operational Pressure NextPlat Corp Q1 2026 Earnings Negative EPS of 042 Amid No Revenue Disclosure Stock Rises Over 16 CNTX Q1 2026 Earnings Context Therapeutics Beats EPS Estimates with NarrowerThanExpected Loss Immunome Inc IMNM Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline Amid Pipeline Progress JELDWEN Holdings Surges Over 13 as Stock Approaches Key Resistance Level McKinley Acquisition Corporation Rights MKLYR Surges 40 Rights Trading at 014 Intuitive Surgical ISRG Drops Over 4 as Key Support Levels Tested Allegro MicroSystems ALGM Rallies 28 Testing Key Resistance Amid Renewed Momentum Gabelli Convertible and Income Securities Fund GCV Edges Lower as Market Narrows Premium Baird Raises Price Target on RideNow Group Following Strong SameStore Sales Performance SLG Q1 2026 Earnings EPS Misses Amid Market Volatility Stock Rises on Operational Resilience Chemours CC Holds Near Support as Trading Volume Remains Subdued